miglitol   Click here for help

GtoPdb Ligand ID: 4842

Synonyms: Glyset® | N-hydroxylethyl-1-deoxynojirimycin
Approved drug PDB Ligand
miglitol is an approved drug (FDA (1996))
Compound class: Synthetic organic
Comment: Miglitol is an iminosugar type drug which inhibits alpha-glucosidase as a mechanism to improve glycemic control in type II diabetics.
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: miglitol

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 5
Rotatable bonds 3
Topological polar surface area 104.39
Molecular weight 207.11
XLogP -2.26
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCCN1CC(O)C(C(C1CO)O)O
Isomeric SMILES OCCN1C[C@H](O)[C@H]([C@@H]([C@H]1CO)O)O
InChI InChI=1S/C8H17NO5/c10-2-1-9-3-6(12)8(14)7(13)5(9)4-11/h5-8,10-14H,1-4H2/t5-,6+,7-,8-/m1/s1
InChI Key IBAQFPQHRJAVAV-ULAWRXDQSA-N
Transporters Moving this Compound Across a Lipid Membrane
Transporter EC number Reaction Reference
Low affinity sodium-glucose cotransporter 4
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
maltase-glucoamylase Mm Inhibitor Inhibition 6.0 – 6.7 pKi - 1
pKi 6.0 – 6.7 (Ki 1x10-6 – 2.11x10-7 M) Inhibition across MGAM catalytic subunits [1]
maltase-glucoamylase Primary target of this compound Hs Inhibitor Inhibition 6.0 pKi - 3
pKi 6.0 (Ki 1x10-6 M) [3]
Description: Inhibition of human recombinant N-terminal subunit of maltase-glucoamylase after 60 mins by glucose oxidase assay
alpha glucosidase Primary target of this compound Hs Inhibitor Inhibition 6.5 pIC50 - 2
pIC50 6.5 (IC50 3.5x10-7 M) [2]